Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors

Cisplatin-based concurrent chemoradiotherapy (CCRT) is a standard treatment for cervical cancer, but nedaplatin-based CCRT is not routinely administered. We evaluated the efficacy and safety of nedaplatin-based CCRT (35 mg/m(2) weekly) and analyzed prognostic factors for survival among 52 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Masateru, Isohashi, Fumiaki, Mabuchi, Seiji, Yoshioka, Yasuo, Seo, Yuji, Suzuki, Osamu, Sumida, Iori, Hayashi, Kazuhiko, Kimura, Tadashi, Ogawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380049/
https://www.ncbi.nlm.nih.gov/pubmed/25428244
http://dx.doi.org/10.1093/jrr/rru101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380049/
https://www.ncbi.nlm.nih.gov/pubmed/25428244
http://dx.doi.org/10.1093/jrr/rru101

Ejemplares similares